Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Authors
Keywords
-
Journal
JOURNAL OF HYPERTENSION
Volume 39, Issue 8, Pages 1522-1545
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-06-09
DOI
10.1097/hjh.0000000000002910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The value of sotagliflozin in patients with diabetes and heart failure detracted by an unexpected ending
- (2021) Massimo Volpe et al. EUROPEAN HEART JOURNAL
- Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
- (2021) Stephan Mueller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials
- (2021) Silvia Oghina et al. JACC-Heart Failure
- Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
- (2021) Husam M. Salah et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction
- (2020) Toshiki Kuno et al. AMERICAN JOURNAL OF CARDIOLOGY
- Covariate adjusted reanalysis of the I-Preserve trial
- (2020) João Pedro Ferreira et al. Clinical Research in Cardiology
- Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future
- (2020) Jan Wintrich et al. Clinical Research in Cardiology
- A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction
- (2020) Muthiah Vaduganathan et al. EUROPEAN HEART JOURNAL
- The neglected issue of cardiac amyloidosis in trials on heart failure with preserved ejection fraction in the elderly
- (2020) Domitilla Russo et al. EUROPEAN JOURNAL OF HEART FAILURE
- Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan
- (2020) Senthil Selvaraj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
- (2020) Michael Böhm et al. LANCET
- Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction
- (2020) Jonathan W. Cunningham et al. JACC-Heart Failure
- Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
- (2020) Rolf Wachter et al. ESC Heart Failure
- Variation in clinical and patient‐reported outcomes among complex heart failure with preserved ejection fraction phenotypes
- (2020) Kelsey M. Flint et al. ESC Heart Failure
- Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology
- (2020) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis
- (2020) Giovanna Gallo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials
- (2020) Costas Thomopoulos et al. JOURNAL OF HYPERTENSION
- Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
- (2020) Jonathan W. Cunningham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure
- (2020) Charles Faselis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension
- (2020) Charles Faselis et al. AMERICAN JOURNAL OF MEDICINE
- Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
- (2020) Finnian R. Mc Causland et al. CIRCULATION
- Assessing left ventricular systolic function: from ejection fraction to strain analysis
- (2020) Brian P Halliday et al. EUROPEAN HEART JOURNAL
- 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
- (2020) Antonio Pelliccia et al. EUROPEAN HEART JOURNAL
- Heart Failure Association of the European Society of Cardiology Update on Sodium Glucose Co‐transporter‐2 Inhibitors in Heart Failure (an update on the Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. The position paper of the Heart Failure Association of the European Society of Cardiology)
- (2020) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hypertension, heart failure, and frailty in older people: A common but unclear situation
- (2020) Miguel Camafort et al. Journal of Clinical Hypertension
- Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
- (2020) Yogesh N.V. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Late-Breaking Clinical Trials - ESC Congress 2020
- (2020) Mark Nicholls EUROPEAN HEART JOURNAL
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
- (2020) Nikolaus Marx et al. Lancet Diabetes & Endocrinology
- Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
- (2020) William T. Abraham et al. JACC-Heart Failure
- Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
- (2020) Karola S. Jering et al. JACC-Heart Failure
- Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
- (2020) Kota Suzuki et al. HYPERTENSION
- The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
- (2019) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Obesity and heart failure with preserved ejection fraction: a paradox or something else?
- (2019) Marijana Tadic et al. HEART FAILURE REVIEWS
- The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association
- (2019) Ignatios Ikonomidis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline
- (2019) James Januzzi et al. EUROPEAN JOURNAL OF HEART FAILURE
- The continuous heart failure spectrum: moving beyond an ejection fraction classification
- (2019) Filippos Triposkiadis et al. EUROPEAN HEART JOURNAL
- Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
- (2019) Hidekatsu Fukuta et al. HEART FAILURE REVIEWS
- Effects of blood pressure lowering in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis
- (2019) Hiroaki Kawano et al. HYPERTENSION RESEARCH
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-sectional analysis of pulsatile hemodynamics across the adult life span
- (2019) Thomas Weber et al. JOURNAL OF HYPERTENSION
- Differences in blood pressure riser pattern is patients with acute heart failure with reduced mid‐range and preserved ejection fraction
- (2019) Tomoya Ueda et al. ESC Heart Failure
- Salt, No Salt or Less Salt For Heart Failure Patients?
- (2019) Muhammad Shahzeb Khan et al. AMERICAN JOURNAL OF MEDICINE
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Heart Rate and Heart Failure With Preserved Ejection Fraction
- (2019) Markus Meyer et al. Circulation-Heart Failure
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2019) Burkert Pieske et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction
- (2019) Melissa A. Lyle et al. JACC-Heart Failure
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
- (2019) Scott D. Solomon et al. CIRCULATION
- Phenomapping of patients with heart failure with preserved ejection fraction using machine learning‐based unsupervised cluster analysis
- (2019) Matthew W. Segar et al. EUROPEAN JOURNAL OF HEART FAILURE
- Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
- (2019) Jasper Tromp et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF
- (2019) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
- (2019) Carolyn S. P. Lam et al. Journal of the American Heart Association
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure
- (2019) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Medical Therapies for Heart Failure With Preserved Ejection Fraction
- (2019) Sverre E. Kjeldsen et al. HYPERTENSION
- Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
- (2019) Giuseppe Vergaro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2019) Amil M. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart failure with preserved ejection fraction: from mechanisms to therapies
- (2018) Carolyn S P Lam et al. EUROPEAN HEART JOURNAL
- Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease
- (2018) Thomas M Gorter et al. EUROPEAN HEART JOURNAL
- Pulsatile arterial haemodynamics in heart failure
- (2018) Thomas Weber et al. EUROPEAN HEART JOURNAL
- Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial
- (2018) Susana Ravassa et al. EUROPEAN JOURNAL OF HEART FAILURE
- Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum
- (2018) Lars H. Lund et al. EUROPEAN JOURNAL OF HEART FAILURE
- Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness
- (2018) Guanghong Jia et al. HYPERTENSION
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
- (2018) David E Kandzari et al. LANCET
- Changes in left ventricular geometry during antihypertensive treatment
- (2018) Massimo Salvetti et al. PHARMACOLOGICAL RESEARCH
- Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Apostolos Tsimploulis et al. JAMA Cardiology
- Cardiorenal Syndrome Revisited
- (2018) Faiez Zannad et al. CIRCULATION
- One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial
- (2018) Sanjiv J. Shah et al. JAMA Cardiology
- Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
- (2018) Ken Lee Chin et al. CARDIOVASCULAR RESEARCH
- Treatment of hypertensive left ventricular hypertrophy
- (2018) Andreas Jekell et al. CURRENT PHARMACEUTICAL DESIGN
- Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
- (2018) Masaru Obokata et al. EUROPEAN HEART JOURNAL
- Empagliflozin directly improves diastolic function in human heart failure
- (2018) Steffen Pabel et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study
- (2017) Roland E Schmieder et al. EUROPEAN HEART JOURNAL
- Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
- (2017) John G F Cleland et al. EUROPEAN HEART JOURNAL
- Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial
- (2017) Senthil Selvaraj et al. EUROPEAN JOURNAL OF HEART FAILURE
- Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
- (2017) Thomas M. Gorter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
- (2017) Michel Komajda et al. EUROPEAN JOURNAL OF HEART FAILURE
- Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic DysfunctionNovelty and Significance
- (2017) Haotian Gu et al. HYPERTENSION
- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction
- (2017) Kevin S. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Geometry as a Confounder When Assessing Ventricular Systolic Function
- (2017) Thomas M. Stokke et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation
- (2017) Simon de Denus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction
- (2017) Daniel H. Katz et al. Journal of Cardiovascular Translational Research
- Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension
- (2017) Thomas M Gorter et al. European Heart Journal-Cardiovascular Imaging
- Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
- (2017) Scott D. Solomon et al. JACC-Heart Failure
- Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
- (2017) Sang Eun Lee et al. JACC-Heart Failure
- The Transition From Hypertension to Heart Failure
- (2017) Franz H. Messerli et al. JACC-Heart Failure
- Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction
- (2017) Inder S. Anand et al. JACC-Heart Failure
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction
- (2017) Erik B. Schelbert et al. JAMA Cardiology
- Contemporary Assessment of Left Ventricular Diastolic Function in Older AdultsClinical Perspective
- (2016) Amil M. Shah et al. CIRCULATION
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
- (2016) Sanjiv J. Shah et al. CIRCULATION
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial
- (2016) Hitesh C. Patel et al. EUROPEAN JOURNAL OF HEART FAILURE
- A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis
- (2016) Nicolas Girerd et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction
- (2016) Dalane W. Kitzman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure – meta-analyses of randomized trials
- (2016) Costas Thomopoulos et al. JOURNAL OF HYPERTENSION
- Prognostic Implications of LV Strain Risk Score in Asymptomatic Patients With Hypertensive Heart Disease
- (2016) Makoto Saito et al. JACC-Cardiovascular Imaging
- Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring
- (2016) Maria R. Costanzo et al. JACC-Heart Failure
- Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneClinical Perspective
- (2015) Amil M. Shah et al. CIRCULATION
- Myocardial strain imaging: how useful is it in clinical decision making?
- (2015) Otto A. Smiseth et al. EUROPEAN HEART JOURNAL
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction
- (2015) Scott D. Solomon et al. EUROPEAN HEART JOURNAL
- Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response
- (2015) David P. Kao et al. EUROPEAN JOURNAL OF HEART FAILURE
- Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?
- (2015) Jozine M. ter Maaten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction
- (2015) Erin D. Unger et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of β-Blockers With and Without Vasodilating Properties on Central Blood Pressure
- (2015) Giacomo Pucci et al. HYPERTENSION
- Plasma Aldosterone and Left Ventricular Diastolic Function in Treatment-Naïve Patients With HypertensionNovelty and Significance
- (2015) Cristiana Catena et al. HYPERTENSION
- Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy
- (2015) Costas Tsioufis et al. JOURNAL OF HYPERTENSION
- Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites
- (2015) Gbenga Ogedegbe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
- (2015) Bryan Williams et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calcium Channel Blockers and Outcomes in Older Patients With Heart Failure and Preserved Ejection Fraction
- (2014) Kanan Patel et al. Circulation-Heart Failure
- Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction
- (2014) Philip B. Adamson et al. Circulation-Heart Failure
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
- (2014) M. Senni et al. EUROPEAN HEART JOURNAL
- Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
- (2014) Jennifer K. Rogers et al. EUROPEAN JOURNAL OF HEART FAILURE
- Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)
- (2014) Michael Böhm et al. EUROPEAN JOURNAL OF HEART FAILURE
- Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis
- (2014) Chirag Bavishi et al. HEART FAILURE REVIEWS
- Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients
- (2014) Peter M. Okin et al. JOURNAL OF HYPERTENSION
- The pathophysiology of heart failure with preserved ejection fraction
- (2014) Barry A. Borlaug Nature Reviews Cardiology
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, Clinical Characteristics, and Outcomes Associated With Eccentric Versus Concentric Left Ventricular Hypertrophy in Heart Failure With Preserved Ejection Fraction
- (2013) Daniel H. Katz et al. AMERICAN JOURNAL OF CARDIOLOGY
- Low-Sodium DASH Diet Improves Diastolic Function and Ventricular–Arterial Coupling in Hypertensive Heart Failure With Preserved Ejection Fraction
- (2013) Scott L. Hummel et al. Circulation-Heart Failure
- Longitudinal Changes in Left Ventricular Stiffness
- (2013) Barry A. Borlaug et al. Circulation-Heart Failure
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND
- (2013) F. P. Brouwers et al. EUROPEAN HEART JOURNAL
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy
- (2013) Milton Packer et al. JACC-Heart Failure
- Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
- (2012) Kazuhiro Yamamoto et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
- (2012) Lars H. Lund et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction
- (2012) Shmuel Schwartzenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
- (2012) Sameer Ather et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Associations between Kidney Function and Subclinical Cardiac Abnormalities in CKD
- (2012) M. Park et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study
- (2012) M. Galderisi et al. European Heart Journal-Cardiovascular Imaging
- Progression from Concentric Left Ventricular Hypertrophy and Normal Ejection Fraction to Left Ventricular Dysfunction
- (2011) Richard V. Milani et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
- (2011) Michael R. Zile et al. CIRCULATION
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction
- (2011) Inder S. Anand et al. Circulation-Heart Failure
- Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study
- (2011) Viviane M. Conraads et al. EUROPEAN JOURNAL OF HEART FAILURE
- Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction
- (2011) Frank Edelmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ethnic Differences in Blood Pressure Response to First and Second-Line Antihypertensive Therapies in Patients Randomized in the ASCOT Trial
- (2010) A. K. Gupta et al. AMERICAN JOURNAL OF HYPERTENSION
- Association of glucose metabolism with diastolic function along the diabetic continuum
- (2010) R. Stahrenberg et al. DIABETOLOGIA
- Epidemiology and clinical course of heart failure with preserved ejection fraction
- (2010) Carolyn S.P. Lam et al. EUROPEAN JOURNAL OF HEART FAILURE
- Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction
- (2010) Arantxa González et al. HYPERTENSION
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
- (2010) Luis Miguel Ruilope et al. LANCET
- Comparison of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Among Those With Versus Without Diabetes Mellitus
- (2009) David Aguilar et al. AMERICAN JOURNAL OF CARDIOLOGY
- Right ventricular function in patients with preserved and reduced ejection fraction heart failure
- (2009) S. Puwanant et al. European Journal of Echocardiography
- Regression of Left Ventricular Mass by Antihypertensive Treatment
- (2009) Robert H. Fagard et al. HYPERTENSION
- Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease
- (2009) Nicola C. Edwards et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Effectiveness of Beta-Blockers in Heart Failure
- (2009) Adrian F. Hernandez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
- (2009) Carolyn S.P. Lam et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Treatment on Myocardial Lysyl Oxidase Expression and Collagen Cross-Linking in Patients With Heart Failure
- (2008) Begoña López et al. HYPERTENSION
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ventricular–Vascular Interaction in Heart Failure
- (2008) Barry A. Borlaug et al. Heart Failure Clinics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started